Calcagno A, et al. Long-term follow-up of HIV-HBV co-infected patients according to the use of anti-HBV active drugs. Abstract O324. HIV/Drug Therapy Glasgow 2018.
Veiligheid en immunogeniciteit van 1 versus 2 doses tetravalent denguevaccin
sep 2017 | Virale infecties